Compare fund portfolios
See how two funds' portfolios overlap. Enter two tickers:
FHCIX vs GGHCX
Shared holdings
30
FHCIX covered by GGHCX
40.13%
GGHCX covered by FHCIX
40.13%
Coverage = share of one portfolio's weight reproduced by the other (overlapping positions, min weight). Top 50 positions per side shown; = held by both — hover a shared position to highlight it in both columns.
FHCIX (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| BOSTON SCIENTIFIC CORP | 6.92% | |
| LILLY ELI and CO | 6.25% | |
| DANAHER CORP | 6.06% | |
| JOHNSON&JOHNSON | 3.49% | |
| Fidelity Securities Lending Cash Central Fund | 3.03% | |
| ABBVIE INC | 2.93% | |
| ARGENX SE SPONSORED ADR | 2.73% | |
| UCB SA | 2.53% | |
| Ascendis Pharma A/S | 2.50% | |
| CVS HEALTH CORP | 2.11% | |
| MASIMO CORP | 2.05% | |
| EDWARDS LIFESCIENCES CORP | 2.01% | |
| VEEVA SYSTEMS-A | 1.87% | |
| THERMO FISHER SCIENTIFIC INC | 1.86% | |
| ALNYLAM PHARMACEUTICALS INC | 1.68% | |
| GILEAD SCIENCES INC | 1.65% | |
| UNITEDHEALTH GRP | 1.54% | |
| MERCK & CO | 1.51% | |
| VIRIDIAN THERAPEUTICS INC | 1.48% | |
| COGENT BIOSCIENCES INC | 1.46% | |
| PENUMBRA INC | 1.39% | |
| MODERNA INC | 1.34% | |
| INSULET CORP | 1.33% | |
| IQVIA HOLDINGS INC | 1.28% | |
| BRIGHTSPRING HEALTH SERVICES INC | 1.27% | |
| NUVALENT INC-A | 1.23% | |
| INSMED INC | 1.17% | |
| LEGEND BIOTECH CORP SPON ADR | 1.07% | |
| CRINETICS PHARMACEUTICALS INC | 1.03% | |
| ROCHE HOLDINGS AG (GENUSSCHEINE) | 1.02% | |
| WAYSTAR HOLDING CORP | 1.01% | |
| MCKESSON CORP | 0.99% | |
| CARIS LIFE SCIENCES INC | 0.98% | |
| ROYALTY PHARMA PLC | 0.94% | |
| STRUCTURE THERAPEUTICS INC ADR | 0.92% | |
| VAXCYTE INC | 0.89% | |
| REPLIGEN CORP | 0.89% | |
| STRYKER CORP | 0.88% | |
| XENON PHARMACEUTICALS INC | 0.84% | |
| DISC MEDICINE INC | 0.84% | |
| PRIVIA HEALTH GROUP INC | 0.82% | |
| INTUITIVE SURGICAL INC | 0.79% | |
| PRAXIS PRECISION MEDICINES INC | 0.77% | |
| ALIGNMENT HEALTHCARE INC | 0.75% | |
| MEDLINE INC-A | 0.74% | |
| BIONTECH SE ADR | 0.71% | |
| CG ONCOLOGY INC | 0.66% | |
| CENTESSA PHARMACEUTICALS LTD ADR | 0.62% | |
| ORUKA THERAPEUTICS INC | 0.61% | |
| 10X GENOMICS INC | 0.60% |
GGHCX (Jan. 31, 2026)
| Security | Weight | |
|---|---|---|
| LILLY ELI and CO | 9.23% | |
| BOSTON SCIENTIFIC CORP | 4.93% | |
| ABBVIE INC | 4.86% | |
| CENCORA INC | 4.58% | |
| GILEAD SCIENCES INC | 3.76% | |
| ASTRAZENECA PLC SPONS ADR | 3.68% | |
| ARGENX SE SPONSORED ADR | 3.50% | |
| JOHNSON&JOHNSON | 3.30% | |
| MCKESSON CORP | 3.11% | |
| Invesco Private Prime Fund | 2.43% | |
| THERMO FISHER SCIENTIFIC INC | 2.26% | |
| HCA HEALTHCARE INC | 1.90% | |
| INTUITIVE SURGICAL INC | 1.80% | |
| Invesco Treasury Portfolio, Institutional Class | 1.78% | |
| WELLTOWER INC | 1.78% | |
| GUARDANT HEALTH INC | 1.70% | |
| Ascendis Pharma A/S | 1.68% | |
| NATERA INC | 1.56% | |
| IDEXX LABS INC | 1.54% | |
| BRIGHTSPRING HEALTH SERVICES INC | 1.49% | |
| INSMED INC | 1.49% | |
| ROYALTY PHARMA-A | 1.44% | |
| UCB SA | 1.40% | |
| UNITEDHEALTH GRP | 1.34% | |
| BRIDGEBIO PHARMA INC | 1.31% | |
| AXSOME THERAPEUTICS INC | 1.27% | |
| TENET HEALTHCARE CORP | 1.19% | |
| VERTEX PHARMACEUTICALS INC | 1.19% | |
| ALNYLAM PHARMACEUTICALS INC | 1.12% | |
| ENCOMPASS HEALTH CORP | 1.07% | |
| INSULET CORP | 1.06% | |
| REGENERON PHARMACEUTICALS INC | 1.06% | |
| METTLER-TOLEDO INTL INC | 1.05% | |
| STRYKER CORP | 1.01% | |
| UNITED THERAPEUTICS CORP DEL | 0.99% | |
| SANDOZ GRP. AG | 0.94% | |
| Invesco Private Government Fund | 0.93% | |
| Invesco Government & Agency Portfolio, Institutional Class | 0.93% | |
| AGILENT TECHNOLOGIES INC | 0.92% | |
| EDWARDS LIFESCIENCES CORP | 0.90% | |
| HALOZYME THERAPEUTICS INC | 0.87% | |
| MADRIGAL PHARMACEUTICALS INC | 0.81% | |
| LONZA GROUP -REG | 0.80% | |
| CARDINAL HEALTH INC | 0.75% | |
| GALDERMA GRP. AG | 0.73% | |
| CVS HEALTH CORP | 0.70% | |
| IONIS PHARMACEUTICALS INC | 0.70% | |
| PROTAGONIST THERAPEUTICS INC | 0.67% | |
| STERIS PLC | 0.61% | |
| LIGAND PHARMACEUTICALS | 0.60% |
Machine-readable: JSON · Markdown. Programmatic access via the agent surface.